Drug Utilization Review 1999 Index
Drug Utilization Review 1999 Index
Clinical pharmacy
New co-infection TB guidelines blast short-course, twice-weekly regimen, JAN:1
Is albumin-furosemide combo on the menu? JAN:10
Add tight lipid control to diabetes playbook, JAN:15
Studies boost hope for osteoporosis treatment, FEB:30
Somatostatin or Sandostatin? MAR:46
Beta-blockers rediscovered, gain primary role in cardiology, APR:49
Statewide stroke project achieves dramatic improvements in warfarin use, JUNE:81
Pharmacogenomics: Gene maps could offer direction for treatment, JULY:97
Seeing opportunities in specialization, pharmacists are turning to oncology, AUG:113
Inflammation not the main suspect in osteoarthritis, SEPT:133
RALES study brings good news about spironolactane, OCT:159
CHF drug therapy getting more complicated, OCT:161
Pharmacist interventions reduce drug errors by 66%, NOV:168
AHA, ACC update AMI guidelines, DEC:179
Medication use evaluations
Phenytoin monitoring in long-term care, JAN:5
Glucosamine sulfate for oesteoarthritis, JAN:7
Programming an automated system for wholesale orders, FEB:21
Assessment of empiric antimicrobial use in limiting resistance, FEB:24
Treating neuroleptic malignant syndrome, MAR:37
Preventing errors with antineoplastic agents, APR:53
Standardized insulin sliding scale, MAY:69
Cholestin used to treat hypercholesterolemia, MAY:71
Computer-generated medication profile review as replacement for automatic stop orders, JUNE:85
Quality assurance program monitors warfarin use, JUNE:88
Pharmacist review of discharge medication, JULY:101
Managing a primary-care dermatology clinic, JULY:105
Cardiology heparin dosing protocols, AUG:119
Thrombolytic therapy for acute MI, SEPT:137
Concomitant use of anxiolytic or sedative-hypnotic agents with SSRIs, OCT(suppl):1
Development, outcomes of ambulatory clinic for H. pylori, NOV(suppl):1
Whole-blood prothrombin time monitors, NOV(suppl):4
Assessing piperacillin/ tazobactam, DEC(suppl):1
COX-2 inhibitors, a review of prostaglandin pathway, DEC(suppl):3
Pharmacokinetics
Study: Albumin or PPF treatment can be deadly, JAN:11
New use for ipratropium: Pediatric emergencies, JAN:14
Sucrose suspected in cases of IVIG-associated renal failure, FEB:29
HIV research highlights conference on infections, MAY:79
ISMP issues error alert on new COX 2 inhibitor, JULY:100
INR superior to unadjusted PT in warfarin therapy, JULY:107
A drug for all addictions: Can science find the panacea addicts can't? OCT:149
Alcoholism: Newer drugs advancing treatment goals, OCT:152
Gender-specific health care new but growing, DEC:176
Significant drug-drug interactions with cisapride (Propulsid), DEC(suppl):8
Pharmacy practice
Pharmacy organizations merge on credentialing, JAN:4
Universal issues lead to pharmacist burnout, JAN:13
Coalition's white paper offers blueprint for pharmacy automation, FEB:17
Use technology to aid your compliance efforts, FEB:19
A day in the life of a clinical pharmacist, MAR:33
States seeking pharmacist reimbursement system, APR:61
PBM satisfaction up slightly, survey shows, APR:62
Is alternative medicine poised for hospital formularies? MAY:65
Computer systems fail to spot harmful interactions, MAY:79
Millennium resources, JUNE:93
IVIG shortage continues, JULY:110
New technology sparks confidentiality debate, AUG:117
Oversight plays catch-up to Internet pharmacy, AUG:127
Exterminating Y2K bugs: Contingency plan a must, SEPT:146
Hold the phone! Will tomorrow's telepharmacy be too complicated? NOV:165
Medication errors: selling the systems approach, DEC:173
Pharmacist counseling of at-risk Medicare patients, DEC:178
On-line giants merging, DEC(suppl):7
Regulation and accreditation
Viagra label warnings strengthened due to deaths, FEB:31
ISMP, FDA launch labeling education programs, MAY:78
FDA reprimands drug companies for ads, JUNE:84
New HEDIS measures, JUNE:94
Pharmacists hail OTC labeling inclusion, JUNE:95
FDA mandates trials in off-label regulations, JULY:100
HCFA reverses Medicaid ruling on serostim, JULY:109
Will pharmacy regulations be based on outcomes, JULY:109
Troglitazone to remain on shelves for now, AUG:116
Lisinopril: FDA considers approving higher doses, NOV:171
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.